Abstract
The N-methyl-D-aspartate (NMDA) subtype of excitatory amino acid receptors are involved in the electrical and behavioural generalization of epileptiform activity within the brain. In rats, both competitive and non-competitive NMDA antagonists induce three dose-dependent stages of EEG patterns: 1) increase in cortical desynchronization periods; 2) increase in amplitude of cortical high frequency (20–30 Hz), low voltage (30–50 µV) background activity; 3) appearance of cortical slow (2–3 Hz) wave-sharp wave complexes. These EEG changes are accompanied by stimulatory-depressive behavioural effects such as stereotypy (circling, head weaving) and ataxia. In the present study, the influence of the prototypic anticonvulsant diphenylhydantoin (DPH) has been tested on the EEG and behavioural effects induced by the non-competitive NMDA antagonists phencyclidine (PCP) and dizocilpine (MK-801) and by the competitive NMDA antagonist cis-4-phosphonomethyl-2-piperidine-carboxylic acid (CGS 19755). Even though DPH (up to 100 mg/kg IP) did not markedly affect basal cortical EEG activity, at doses of 10–100 mg/kg IP it potentiated all the EEG effects induced by the NMDA antagonists. These data support involvement of NMDA neurotransmission in the pharmacological effects of DPH.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565–575
Collingridge GH, Lester RAJ (1989) Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 40:143–208
Croucher MJ, Collins JF, Meldrum BS (1982) Anticonvulsant action of excitatory amino acid antagonists. Science 216:899–901
Croucher MJ, Bradford HF, Sunter DC, Watkins JC (1988) Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur J Pharmacol 152:29–38
Edmonds HL, Stark LG, Hollinger MA (1974) The effects of diphenylhydantoin, phenobarbital and diazepam on the penicillin-induced epileptogenic focus in the rat. Exp Neurol 45:377–386
Kayama Y (1982) Ketamine and EEG seizure waves: interaction with antiepileptic drugs. Br J Anaesth 54:879–883
Luby ED, Gottlieb JS, Cohen BD, Rosebaum G, Domino EF (1962) Model psychoses and schizophrenia. Am J Psychiatry 119:61–67
Meldrum BS (1985) Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68:113–122
Mironov SL, Lux HD (1992) Glutamate selectively increase the high-threshold Ca2+ channel current in sensory and hippocampal neurons. Brain Res 580:341–344
Potter PE, Detwiller P, Thorne B, Moskal JR (1991) Diphenylhydantoin attenuates hypoxia-induced release of [3H] glutamate from rat hippocampal slices. Brain Res 558:127–130
Sagratella S, Scotti de Carolis A, Pezzola A, Popoli P (1991) Behavioural and electroencephalographic interactions between haloperidol and PCP/sigma ligands in the rats. Psychopharmacology 105:485–491
Sagratella S, Pezzola A, Popoli P, Scotti De Carolis A (1992) Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats. Psychopharmacology 109:277–282
Sato K, Morimoto K, Okamoto M (1988) Anticonvulsant action of a non-competitive antagonists of NMDA receptors (MK 801) in the kindling model of epilepsy. Brain Res 463:12–20
Sechi GP, Caria MA, Melis F, Tanca S, Canu M, Deserra F, Rosati G (1992) Effects of ketamine anesthesia on phenytoin biodisposition. Epilepsia 33:366–371
Sherman AD, Hegwood TS, Baruah S (1991) Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics. Biol Psychiatry 30:1191–1198
Stark LG, Edmonds HL, Keesling P (1974) Penicillin-induced epileptogenic foci-I: time course and the anticonvulsant effects of diphenylhydantoin and diazepam. Neuropharmacology 13:261–267
Stasheff SF, Anderson WW, Clark S, Wilson WA (1989) NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 245:648–651
Wiler AR, Ward AA (1980) In: Lockard JS, Ward AA (eds) Epilepsy: a window to brain mechanisms Raven Press, New York, pp 51–68
Willetts J, Balster RL, Leander JD (1990) The behavioural pharmacology of NMDA receptor antagonists. TIPS 11:423–428
Yaari Y, Selzer ME, Pincus JH (1986) Phenytoin: mechanisms of its anticonvulsant action. Ann Neurol 20:171–184
Zeng YC, Pezzola A, Scotti de Carolis A, Sagratella S (1992) Inhibitory influence of morphinans on ictal and interictal EEG changes induced by cortical application of penicillin in rabbits: a comparative study with NMDA antagonists and pentobarbitone. Pharmacol Biochem Behav 43:651–656
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Popoli, P., Pèzzola, A. & Sagratella, S. Diphenylhydantoin potentiates the EEG and behavioural effects induced by N-methyl-D-aspartate antagonists in rats. Psychopharmacology 113, 471–475 (1994). https://doi.org/10.1007/BF02245225
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245225